Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

Clinical trial NCT00496808 · COMPLETED

Trial details

NCT number: NCT00496808
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Ductal Carcinoma In Situ

Start date: 2005-03-01
Primary completion: 2010-11-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.